According to Tonix Pharmaceuticals's latest financial reports the company's current revenue (TTM) is $7.76 M. In 2022 the company made a revenue of N/A a decrease over the years 2021 revenue that were of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $7.76 M | |
2022 | N/A | |
2021 | N/A | |
2020 | N/A | |
2019 | N/A | |
2018 | N/A | |
2015 | N/A | |
2014 | N/A | |
2013 | N/A | |
2012 | N/A | |
2011 | N/A | |
2010 | N/A | |
2009 | N/A |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Aerie Pharmaceuticals AERI | $0.21 B | 2,654.13% | ๐บ๐ธ USA |
Eagle Pharmaceuticals
EGRX | $0.25 B | 3,215.54% | ๐บ๐ธ USA |